198 related articles for article (PubMed ID: 1697565)
1. The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide.
MacPhee IA; Day MJ; Mason DW
Immunology; 1990 Aug; 70(4):527-34. PubMed ID: 1697565
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
4. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
5. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
MacPhee IA; Mason DW
J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.
Happ MP; Wettstein P; Dietzschold B; Heber-Katz E
J Immunol; 1988 Sep; 141(5):1489-94. PubMed ID: 2457618
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
8. Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions.
Lemire JM; Weigle WO
J Immunol; 1986 Nov; 137(10):3169-74. PubMed ID: 2430015
[TBL] [Abstract][Full Text] [Related]
9. Experimental allergic encephalomyelitis (EAE): role of B cell and T cell epitopes in the development of EAE in Lewis rats.
Hashim GA; Day ED; Carvalho E; Abdelaal A
J Neurosci Res; 1987; 17(4):375-83. PubMed ID: 2442406
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
[TBL] [Abstract][Full Text] [Related]
11. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
Matsumoto Y; Fujiwara M
Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
[TBL] [Abstract][Full Text] [Related]
14. Experimental allergic encephalomyelitis and vaccination-induced resistance in DA rats.
Bouwer HG; Hinrichs DJ
Cell Immunol; 1997 Jan; 175(1):92-8. PubMed ID: 9015193
[TBL] [Abstract][Full Text] [Related]
15. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
[TBL] [Abstract][Full Text] [Related]
16. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
17. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein.
Mannie MD; Paterson PY; U'Prichard DC; Flouret G
J Immunol; 1989 Apr; 142(8):2608-16. PubMed ID: 2467932
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction.
O'Brien NC; Charlton B; Cowden WB; Willenborg DO
J Immunol; 1999 Dec; 163(12):6841-7. PubMed ID: 10586085
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
Holda JH; Silberg D; Swanborg RH
J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
[TBL] [Abstract][Full Text] [Related]
20. Antibodies which block anti-myelin basic protein antibodies associated with development of experimental autoimmune encephalomyelitis in Wistar rats.
Vilcaes AA; Degano AL; López PH; Nores GA; Roth GA
J Neuroimmunol; 2005 Jul; 164(1-2):31-6. PubMed ID: 15950291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
